Qingmao Yang

Qingmao Yang

Auto-generated profile, based on publicly available information

Qingmao Yang

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
ZPZehan Pang
Zehan Pang
ATAo Tang
Ao Tang
YHYujie He
Yujie He
JFJunfen Fan
Junfen Fan
QYQingmao Yang
Qingmao Yang
HFHuahao Fan
Huahao Fan
SUMMARY: SARS-CoV-2 can not only cause respiratory symptoms but also lead to neurological complications. Research has shown that more than 30% of SARS-CoV-2 patients present neurologic symptoms during COVID-19 (A. Pezzini and A. Padovani, Nat Rev Neurol 16:636–644, 2020, https://doi.org/10.1038/s41582-020-0398-3 ). Increasing evidence suggests that SARS-CoV-2 can invade both the central nervous system (CNS) (M.S. Xydakis, M.W. Albers, E.H. Holbrook, et al. Lancet Neurol 20: 753–761, 2021 https://doi.org/10.1016/S1474-4422(21)00182-4 ) and the peripheral nervous system (PNS) (M.N. Soares, M. Eggelbusch, E. Naddaf, et al. J Cachexia Sarcopenia Muscle 13:11–22, 2022, https://doi.org/10.1002/jcsm.12896 ), resulting in a variety of neurological disorders. This review summarized the CNS complications caused by SARS-CoV-2 infection, including encephalopathy, neurodegenerative diseases, and delirium. Additionally, some PNS disorders such as skeletal muscle damage and inflammation, anosmia, smell or taste impairment, myasthenia gravis, Guillain-Barré syndrome, ICU-acquired weakness, and post-acute sequelae of COVID-19 were described. Furthermore, the mechanisms underlying SARS-CoV-2-induced neurological disorders were also discussed, including entering the brain through retrograde neuronal or hematogenous routes, disrupting the normal function of the CNS through cytokine storms, inducing cerebral ischemia or hypoxia, thus leading to neurological complications. Moreover, an overview of long-COVID-19 symptoms is provided, along with some recommendations for care and therapeutic approaches of COVID-19 patients experiencing neurological complications.

4 August 2026 in Chinese Journal of Chemical Engineering
Verified
Journal Article
Closed access
QYQingmao Yang
Qingmao Yang
AHAnyan He
Anyan He
JTJunyan Tan
Junyan Tan
WZWeichen Zhao
Weichen Zhao
HWHaoyi Wu
Haoyi Wu
CSChun Shen
Chun Shen